Neutralizing anti-IL-6 antibodies have been described in recurrent episodes of bacterial infections without an increase in C-reactive protein (CRP) level, consistent with impaired IL-6 mediated synthesis of this acute-phase reactant by the liver [41,42]. Here, IL6 is linked to bacterial infectious disease.